Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol Window of Opportunity in Breast Cancer
NCT02596867Phase 2Terminated
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Sep 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in breast cancer, sponsored by Texas Tech University Health Sciences Center. Started Sep 2015; status: terminated.
02
Drugs
propranolol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02596867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596867.